Literature DB >> 25911848

High frequency of BRAF proto-oncogene hot spot mutation V600E in cohort of colorectal cancer patients from Ahvaz City, southwest Iran.

Javad Mohammadi Asl, Shekoufeh Almasi, Mohammad Amin Tabatabaiefar.   

Abstract

Colorectal cancer (CRC) is one of the most common forms of cancer around the world. Sporadic CRCs are caused by accumulation of mutations in essential genes regulating normal proliferation and differentiation of cells. The proto-oncogene BRAF encoded by the BRAF gene is involved in the RAS/RAF/MAPK pathway of signal transduction during cell growth. Acquired mutations in BRAF have been found at high frequencies in adult patients with papillary thyroid carcinoma and sporadic CRC. One of the predominant hot spot point mutations is T1799A (V600E) mutation among a cohort of CRC patients from Ahvaz city, southwest Iran. The aim of this study was to estimate the frequency of V600E mutation in CRC patients from Ahvaz city, southwest Iran. We analyzed exon 15 of the BRAF gene in isolated DNA from 80 Formalin Fixed Paraffin-embedded (FFPE) CRC tumor tissues using PCR-RFLP method. Data were analyzed using SPSS statistical program. According to our results 37 out of 80 cases (46.25%) were heterozygous for the mutation while the remaining 43 cases (53.75%) had normal homozygous genotype. No homozygous mutant genotype was found. Based on our findings, the frequency of V600E mutation appears to be significantly increased among CRC patients of the studied population but there was no significant relationship between genotypes and age and sex. In conclusion, these findings might prove the effect of V600E mutation on CRC pathogenesis. However, the exact effect of the mutation in CRC progression requires further work.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25911848     DOI: 10.3923/pjbs.2014.565.569

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  6 in total

1.  Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.

Authors:  Humaid O Al-Shamsi; Jeremy Jones; Yazan Fahmawi; Ibrahim Dahbour; Aziz Tabash; Reham Abdel-Wahab; Ahmed O S Abousamra; Kenna R Shaw; Lianchun Xiao; Manal M Hassan; Benjamin R Kipp; Scott Kopetz; Amr S Soliman; Robert R McWilliams; Robert A Wolff
Journal:  J Gastrointest Oncol       Date:  2016-12

2.  A Systematic Review and Meta-analysis on the Occurrence of Biomarker Mutation in Colorectal Cancer among the Asian Population.

Authors:  Hafeez Afolabi; Salzihan Md Salleh; Zaidi Zakaria; Ch'ng Ewe Seng; Siti Norasikin Binti Mohd Nafil; Ahmad Aizat Bin Abdul Aziz; Yusuf Wada; Ahmad Irekeola
Journal:  Biomed Res Int       Date:  2022-06-23       Impact factor: 3.246

3.  Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran.

Authors:  Roya Dolatkhah; Mohammad Hossein Somi; Iraj Asvadi Kermani; Morteza Bonyadi; Bita Sepehri; Kamal Boostani; Saleh Azadbakht; Nikou Fotouhi; Faris Farassati; Saeed Dastgiri
Journal:  Onco Targets Ther       Date:  2016-12-07       Impact factor: 4.147

Review 4.  Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer.

Authors:  Mehrdad Zeinalian; Morteza Hashemzadeh-Chaleshtori; Rasoul Salehi; Mohammad Hassan Emami
Journal:  Adv Biomed Res       Date:  2018-02-16

Review 5.  KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis.

Authors:  Abolfazl Yari; Asiyeh Afzali; Mostafa Aalipour; Mehran Nakheai; Mohammad Javad Zahedi
Journal:  Caspian J Intern Med       Date:  2020

6.  Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis.

Authors:  Alireza Tabibzadeh; Fahimeh Safarnezhad Tameshkel; Yousef Moradi; Saber Soltani; Maziar Moradi-Lakeh; G Hossein Ashrafi; Nima Motamed; Farhad Zamani; Seyed Abbas Motevalian; Mahshid Panahi; Maryam Esghaei; Hossein Ajdarkosh; Alireza Mousavi-Jarrahi; Mohammad Hadi Karbalaie Niya
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.